[go: up one dir, main page]

CA2600337A1 - Marqueurs de melanome - Google Patents

Marqueurs de melanome Download PDF

Info

Publication number
CA2600337A1
CA2600337A1 CA002600337A CA2600337A CA2600337A1 CA 2600337 A1 CA2600337 A1 CA 2600337A1 CA 002600337 A CA002600337 A CA 002600337A CA 2600337 A CA2600337 A CA 2600337A CA 2600337 A1 CA2600337 A1 CA 2600337A1
Authority
CA
Canada
Prior art keywords
melanoma
expression
seq
tspy1
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002600337A
Other languages
English (en)
Inventor
William Gallagher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Dublin
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2600337A1 publication Critical patent/CA2600337A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002600337A 2005-03-02 2006-03-02 Marqueurs de melanome Abandoned CA2600337A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0504302.1 2005-03-02
GB0504302A GB0504302D0 (en) 2005-03-02 2005-03-02 Markers for melanoma
PCT/GB2006/000756 WO2006092610A2 (fr) 2005-03-02 2006-03-02 Marqueurs de melanome

Publications (1)

Publication Number Publication Date
CA2600337A1 true CA2600337A1 (fr) 2006-09-08

Family

ID=34430497

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002600337A Abandoned CA2600337A1 (fr) 2005-03-02 2006-03-02 Marqueurs de melanome

Country Status (4)

Country Link
EP (1) EP1859049A2 (fr)
CA (1) CA2600337A1 (fr)
GB (1) GB0504302D0 (fr)
WO (1) WO2006092610A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100021424A1 (en) 2006-06-02 2010-01-28 Vincent Brichard Method For Identifying Whether A Patient Will Be Responder or Not to Immunotherapy
EP2639315A1 (fr) * 2007-05-11 2013-09-18 The Johns Hopkins University Biomarqueurs pour mélanomes
US20090220980A1 (en) * 2007-12-28 2009-09-03 John Wayne Cancer Institute Use of methylation status of mint loci and tumor-related genes as a marker for melanoma and breast cancer
GB0917457D0 (en) 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method
EA019599B1 (ru) * 2010-09-13 2014-04-30 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук Способ диагностики меланомы человека на основании определения уровня экспрессии гена phf10, диагностический набор
GB201204785D0 (en) 2012-03-19 2012-05-02 Queen Mary & Westfield College Method for determining prognosis of prostate cancer in a subject
EP4265740A3 (fr) 2013-03-14 2024-04-24 Castle Biosciences, Inc. Méthodes de prédiction du risque de métastase dans un mélanome cutané
EP2971156B1 (fr) 2013-03-15 2020-07-15 Myriad Genetics, Inc. Gènes et signatures géniques pour le diagnostic et le traitement du mélanome
WO2016003810A1 (fr) 2014-07-02 2016-01-07 Myriad Genetics, Inc. Gènes et signatures génétiques pour le diagnostic et le traitement du mélanome
EP3314020A1 (fr) * 2015-06-29 2018-05-02 The Broad Institute Inc. Expression génique tumorale et micro-environnementale, compositions de matières et ses procédés d'utilisation
CN110241219B (zh) * 2019-07-18 2024-04-16 北京泱深生物信息技术有限公司 Myom3在黑色素瘤转移中的应用
JP2023524750A (ja) * 2020-05-04 2023-06-13 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ メラノーマの検出

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390687A1 (fr) * 1999-12-10 2001-06-14 Whitehead Institute For Biomedical Research Genes de metastase et utilisations de tels genes
JP2006500946A (ja) * 2002-09-30 2006-01-12 オンコセラピー・サイエンス株式会社 精巣精上皮腫の診断方法
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법

Also Published As

Publication number Publication date
GB0504302D0 (en) 2005-04-06
EP1859049A2 (fr) 2007-11-28
WO2006092610A3 (fr) 2006-12-07
WO2006092610A2 (fr) 2006-09-08

Similar Documents

Publication Publication Date Title
Jiang et al. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma
Wang et al. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer
US8785614B2 (en) Aberrantly methylated genes in pancreatic cancer
Schotte et al. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia
EP2185726B1 (fr) Nouveaux polymorphismes nucléotidiques uniques et combinaisons de nouveaux polymorphismes connus permettant de déterminer l'expression spécifique d'allèle du gène igf2
US20080221056A1 (en) Early Detection and Prognosis of Colon Cancers
EP2527472B1 (fr) Une lésion génétique associée à un cancer
Ortmann et al. Aberrant hypomethylation of the cancer–testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia
JP2009539404A (ja) 大腸癌の早期検出および予後のためのメチル化マーカー
JP2005532041A (ja) 後生的に沈黙化された腫瘍抑制遺伝子のゲノムスクリーニング
WO2013130880A1 (fr) Marqueurs de gène hyperméthylé pour le cancer de la tête et du cou
CA2600337A1 (fr) Marqueurs de melanome
EP2971075B1 (fr) Procédés et compositions pour la détection de mutations dans le gène pi3kca humain (pik3ca)
US20080085867A1 (en) Early detection and prognosis of colon cancers
Okamura et al. Identification of the bleomycin hydrolase gene as a methylated tumor suppressor gene in hepatocellular carcinoma using a novel triple-combination array method
US20090093424A1 (en) Markers for melanoma
EP2406393B1 (fr) Nouveaux marqueurs pour la détection du cancer de la vessie
EP2436763B1 (fr) Procédé pour évaluer la métastase dans des ganglions lymphatiques de cancer ou le risque de celle-ci, et kit d'évaluation rapide pour ledit procédé
EP1840227A1 (fr) Marqueurs pour mélanome
WO2009071920A2 (fr) Procédés d'identification de gènes rendus épigénétiquement silencieux et de nouveaux gènes suppresseurs de tumeur
JP2025519538A (ja) 悪性肺結節及び肺がんを検出するための方法、組成物、及びキット
Cheng Integrative genetic and epigenetic studies to identify prostate cancer genes at chromosome 8p
Wong The role of DNA methylation in the development of colorectal neoplasia
Ang DNA methylation in colorectal cancer

Legal Events

Date Code Title Description
FZDE Discontinued